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Type 2 Diabetes (T2D)
Janice Loney BSN, RN
Otterbein University, Westerville, Ohio
Introduction
Type 2 diabetes (T2D) is long-term, chronic
condition affecting the way the body
processes glucose.
More common than type 1 diabetes, T2D
involves the body not producing enough
insulin or resistance to insulin (Leonitis &
Hess-Fischl, 2019).
Previously considered adult onset, evidence
reveals increased prevalence of T2D in
children, contributing to the growing
number of 29.1 million people in the US with
this disease (Cornell, 2015).
A progressive disease, T2D predisposes
individuals to heart disease, stroke,
retinopathy, neuropathy, dementia, renal
disease, amputation and early death (Skyler
et al., 2017).
Risk of developing T2D increases after age 40
(McCance & Huether, 2019).
People with T2D spend more on healthcare,
have fewer productive years and miss more
work days compared to people who don’t
have T2D.
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In the last 20 years, the number of adults
diagnosed with diabetes has more than
tripled as the US population has aged and
become more overweight (“Type 2 DiabetesData & Statistics,” 2019).
Diabetes care has a major economic impact
worldwide, as a future family nurse
practitioner (FNP) patient education on T2D
risk factors, disease process and medical
management are vital to halt this growing
epidemic.
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Underlying Pathophysiology

Working in a Case Management role, this graduate nurse
experiences first hand recurrent hospitalizations requiring
patient education, utilization of resources and support to
manage diabetes. C.P. is a 52-year-old man who most recently
presented with A-fib, , neuropathy, open sores on both feet,
hypertension, obesity as well as being a smoker. Initial blood
glucose was 243 and when asked about home medications for
diabetes patient exclaimed, “I don’t have diabetes, my blood
sugar is just high”. Treatment of dysrhythmia, regulation of
blood glucose, levels, treatment of open wounds required
medication therapies and education.
Obesity contributes to insulin resistance whereby serum levels
of leptin, adiponectin and inflammation affect insulin synthesis
and resistance (McCance & Huether, 2019).
People with diabetes who smoke have increased risk of serious
complications, such as heart disease, kidney disease, and poor
blood flow in legs and feet predisposing them to infections and
neuropathy.
Collaborative education with a Diabetic Educator involved
obtaining glucometer with education on use, storage of
supplies, medication compliance, diet & lifestyle modifications
as well as the importance of smoking cessation.
Established patient with Chronic Care Management team for
ongoing education, support and symptom management for
overall health.
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Polydipsia
Polyuria
Polyphagia
Hyperglycemia
Fatigue
Blurred vision
Recurrent infections
Poor wound healing
Weight loss
Areas darkened skin,, usually in armpits
and neck
Possibly asymptomatic
Leonitis & Hess-Fischl, 2019
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Understanding T2D: food digested is used as fuel (glucose) for
the body’s cells.
Glucose requires the hormone insulin to enter the cells.
Produced by the pancreas, insulin is released into the
bloodstream in response to the presence of glucose.
In T2D, cells don’t respond properly to insulin, therefore less
glucose moves into cells (insulin resistance)
Less glucose entering cells produces buildup of glucose in
bloodstream (hyperglycemia).

Chronic hyperglycemia leads to CAD, PAD, CVD ( Brunton, 2016).
Blood vessels damaged by consistent hyperglycemia lead to cataracts and retinopathy in the
eyes, likewise diabetic neuropathy develops when blood vessels in nerves undergo damage.
Peripheral neuropathy is loss of sensation in hands and more commonly feet from chronic nerve
damage which leads to undetected sores predisposing individuals to infections.
Gluconeogenesis occurs in the kidneys and liver, further exacerbating hyperglycemia.
Diabetic nephropathy may develop as the kidneys are unable to filter impurities from blood
(Skyler et al., 2017).
Medications to treat T2D along with dietary management may lead to hypoglycemia as blood
glucose levels regulate.
McCance & Huether, 2019

Implications for Nursing Care
•

Insulin Resistance

Signs & Symptoms

.
Significance
of Underlying Pathophysiology

Abnormalities of insulin signaling pathway with gradual progression.
Pancreatic beta cell function= ability to sense blood glucose level, insulin synthesis and
secrete insulin.
Insulin necessary to unlock cells, thereby promoting glucose removal from the blood.
Cells in muscle, liver and adipose tissue ineffective at absorbing insulin, likewise cannot
regulate glucose levels (Brunton, 2016, p.3).
Inability of cells to respond to insulin leads to insulin resistance.
Hormones in GI tract such as amylin and ghrelin are diminished in T2D, thereby slowing
gastric emptying, GI motility and promoting hunger.
Impaired regulation of hepatic glucose, the liver overproduces glucose due to developed
resistance to suppressive effect of insulin.
Insulin resistance develops with ectopic fat deposition in the liver and muscle.
Accumulation of fat in the pancreas contributes to decline in beta cell function, islet
inflammation and eventual beta cell death (Skyler et al., 2017, p. 244).
High levels of glucose in blood signal pancreas to secrete more insulin
As disease progresses, pancreas is unable to keep up with the demand which leads to
insulin insufficiency and finally hyperglycemia
Brunton, 2016

Risk Factors
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Obesity
•
Family history- 40% greater if one
•
parent has the disease
•
Age, older than 45 years
•
Physical inactivity
•
Hypertension
•
Diet/diet during pregnancy
Male sex higher prevalence than female •

Metabolic syndrome
Smoking increases incidence by 30-40%
Sleep quality/quantity
Depression
Psychosocial factors
Ethnicity (Black, Pacific Islander, Asian
American, or Native American)
Low socioeconomic status
Ley et al., 2016
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Patient and family education regarding disease process , signs and symptoms of
hyper/hypoglycemia and prevention of T2D complications.
Screening for at risk individuals to prevent or delay progression of T2D (Skyler et al., 2016).
Nutritional management for balanced and healthy diet promotes glycemic control and
healthy weight improving insulin sensitivity.
Personalized approach for a regular exercise regimen thereby encouraging weight loss.
Monitor one’s feet, skin and eyes via annual check-up with their healthcare provider.
Lab testing of blood and urine to check A1C, ketones in urine and cholesterol levels.
Education on necessary diabetic supplies; glucometer, test strips, syringes/needles and
proper storage/disposal for optimal use.
Regular self -monitoring of blood glucose and tracking for target range.
Instruction on medication administration, oral medication and insulin if needed.
Coaching on support services and programs such as, Diabetes Self-management Education
and Support Services (DSMES) provide a tailored approach to care utilizing evidence-based
standards (“Managing Diabetes,” 2018).
Referral to resource The American Diabetes Association (ADA) at 800-342-2383 or
www.diabetes.org.
Education on smoking cessation in conjunction with nicotine replacement therapy to
prevent further complications associated with T2D.
Utilization/implementation of telehealth delivery of care supports patients in rural areas,
where diabetes incidence is 17% more prevalent (“Type 2 Diabetes-Data & Statistics,” 2019).

Conclusion

T2D is a chronic condition and if not properly managed can result in serious health
complications and death.
Approximately 29.1 million people in the USA have diabetes; if current trend continues
percentage is estimated to be 592 million people worldwide by 2035 (Cornell, 2015).
Early diagnosis impacts the severity of disease. The treatment goal is restoration of
normal blood glucose and correction of related metabolic disorders.
In 2016, the CDC partnered with the ADA, the American Medical Association and the Ad
Council promoting the first prediabetes awareness campaign. Sites such as,
DoIHavePrediabetes .org allows people to inquire their risk of diabetes through quick
test as well as providing links to nationwide sites for valuable information to improve
health.
Prevention is best, however once diagnosed with T2D managing disease involves lifestyle
and dietary changes with support of healthcare professionals that promote
health and improve quality of life.

